Fig. 2: IP-10 is significantly elevated in maternal and infant serum following COVID-19 infections in pregnancy.

A Maternal serum IP-10 expression in Control vs COVID cohorts. B Maternal serum IP-10 sub-analysis among Control, Early COVID and Late COVID cohorts. C Infant serum IP-10 expression in Control vs COVID cohorts. D Infant serum IP-10 sub-analysis among Control, Early COVID and Late COVID cohorts. E Correlation analysis of IP-10 expression in maternal-infant dyads. Control: as described in Fig.Ā 1. COVID: Mothers positive for SARS-CoV-2 in pregnancy. Early COVID: as described in Fig.Ā 1. Late COVID: as described in Fig.Ā 1. *pā<ā0.05, **pā<ā0.01, ***pā<ā0.001.